Anzeige
Mehr »
Dienstag, 10.02.2026 - Börsentäglich über 12.000 News
Breaking News: Pacifica meldet neue hochgradige Entdeckung und genau deshalb kann der Markt das nicht ignorieren
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
190 Leser
Artikel bewerten:
(0)

Dr. Melanie Novak Joins Jagannathan Neurosurgery

Will Provide Non-operative Management to Patients with Interventional Pain Needs

TROY, MI / ACCESSWIRE / September 26, 2018 / Jagannathan Neurosurgery, a multi-disciplinary Neurosurgery, Neurology and Pain practice which has five offices throughout Michigan, including two in the Upper Peninsula, is pleased to announce the addition of Dr. Melanie M. Novak. She will begin her role at the West Branch and Troy locations as an interventional pain specialist for the practice's new and established patients.

Dr. Melanie Novak has almost three decades of comprehensive pain management experience. She is board-certified in anesthesiology and pain medicine. Her three specialty areas include acute, chronic and cancer pain. Common treatment options include epidural steroid injections, cervical and lumbar nerve block injections, various joint injections and rhizotomies.

Dr. Novak is well versed in managing chronic pain using different types of injection treatments and medications, as well as physical and behavior therapy. She comes to Jagannathan Neurosurgery from the PCA Pain Care Center in Battle Creek, Michigan, affiliated with Bronson Battle Creek Hospital.

'Having Dr. Novak on staff enhances our ability to provide comprehensive care to patients,' explained Dr. Jagannathan. 'As physicians, we continue to learn more about the complexity of pain, and to emphasize the value of traditional and novel non-operative treatments before surgery. It will be helpful to have a talented professional like Dr. Novak on staff to lead these efforts.'

Dr. Novak earned a bachelor's degree in biology from Marquette University and completed her medical education and training at Northwestern University's Feinberg School of Medicine. Post-graduation, she completed her residency in anesthesiology at Medical College of Georgia, then completed a pain management fellowship at Northwestern Memorial Hospital in Chicago. She is a Diplomate of the American Board of Pain Medicine and the American Board of Anesthesiology.

'I'm looking forward to the next chapter of my patient care experience,' Novak stated. 'Dr. Jagannathan's practice has made it a point to put a special focus on the patient experience, and I'm excited to put my skills to work in the environment he's created.'

Dr. Novak has won multiple awards for her practice, including being named a Vitals Top-10 Michigan Doctor in 2014 and Patient's Choice Award in 2018, and is a three-time winner of the Compassionate Doctor Recognition Award - 2015, 2016 and 2018.

For more information on Dr. Melanie Novak and Jagannathan Neurosurgery, please visit http://mi-neurosurgery.com.

About Jagannathan Neurosurgical Institute

The Jagannathan Neurosurgical Institute is comprised of five medical practice locations - Troy, Garden City, West Branch, Newberry and Sault Ste. Marie - serving southeast, central and northern Michigan, including the Upper Peninsula. Jay Jagannathan, M.D. FAANS, and his associate physicians, nurse practitioner and physician assistant utilize two state-of-the-art in-office procedure locations and operate out of Garden City Hospital (part of Prime Healthcare), Michigan Surgical Hospital and Mid-Michigan Medical Center - West Branch (part of the University of Michigan Medical System).

Dr. Jagannathan is a board-certified neurosurgeon specializing in cranial and spinal surgery with a key focus on utilizing the latest minimally invasive techniques.

SOURCE: Jagannathan Neurosurgery



View source version on accesswire.com:
https://www.accesswire.com/512818/Dr-Melanie-Novak-Joins-Jagannathan-Neurosurgery

© 2018 ACCESS Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.